Search results
Autoimmune-mediated skin findings after COVID-19 vaccination include leucocytoclastic vasculitis, lupus erythematosus and immune thrombocytopenia. Functional angiopathies (chilblain-like lesions, erythromelalgia) may also be observed. Pityriasis rosea-like rashes and reactivation of herpes zoster have also been reported after COVID-19 vaccination.
- T. Gambichler, S. Boms, L. Susok, H. Dickel, C. Finis, N. Abu Rached, M. Barras, M. Stücker, D. Kasa...
- 2021
Apr 15, 2021 · Between December 2020 and February 2021, it counted 414 cases of skin reactions after an mRNA vaccine. The various types of potential reactions were detailed in a report published online recently ...
May 3, 2023 · Since then, the dermatological literature has provided descriptions of other skin manifestations and research papers on pathogenesis and immunology, treatment and the after-effects of infection or post-COVID syndrome (long COVID). 2 Longer-term skin manifestations may include chronic urticaria, recurrent pernio, telogen effluvium, capillaritis and exacerbation of pre-existing skin conditions ...
- What Are The Covid-19 Vaccines?
- How Do The Covid-19 Vaccines differ?
- What Are The Common Types of Skin Reaction to Covid-19 Vaccines?
- How Common Are Cutaneous Reactions After Covid-19 Vaccination?
- What Are The Uncommon Mild Skin Reactions to Covid-19 Vaccines?
- What Are The Uncommon Serious Skin Reactions to Covid-19 Vaccines?
- How Are The Covid-19 Skin Reactions Treated?
The coronavirus disease 2019 (COVID-19) pandemic has led to the development and approval of vaccines against the responsible virus — severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2). More than 100 companies and institutions worldwide have developed vaccine candidates.
Current approved vaccinesrely on a nucleic-acid-based vaccine platform 1. Messenger ribonucleic acid (mRNA) eg, Pfizer/BioNTech + Fosun Pharma, Moderna + National Institute of Allergyand Infectious Diseases 2. Viral vectorplatforms eg, AstraZeneca + University of Oxford, Janssen Pharmaceutical 3. Inactivated virus eg, Sinopharm + China National Bio...
The majority of current literature regarding cutaneousreactions relate specifically to mRNA COVID-19 vaccinations. The spectrum of reported cutaneous reactions after mRNA vaccination include: 1. Local site reaction 1.1. Swelling, erythema, and pain in the vaccinated arm. 1.2. Medianonset of 1 day after vaccination. 2. Urticaria 2.1. Median onset re...
In one study, cutaneous reactions within 3 days after receiving the vaccine were reported in 1.9% of individuals after receiving their first dose of the mRNA COVID vaccine (Pfizer-BioNtech and Moderna). The majority of cutaneous reactions after COVID-19 vaccination occur in women (around 90%). Erythema and itching (other than at the injection site)...
Exacerbation of underlying skin conditionSevere cutaneous adverse reactionsare very rare. The established vaccines have a satisfactory safety profile. Management should be directed at the presenting skin condition, however most of the encountered skin reactions are self-limiting. Anaphylaxis requires prompt treatment with intramuscular adrenalineand oxygen. Unlike anaphylaxis, cutaneous a...
In this study, we found that COVID-19 vaccines were well tolerated by advanced skin cancer patients treated with ICIs: The rate of general side effects was lower than that seen in preliminary clinical data from vaccination studies [10, 11].
Below is a list of resources and information specific to COVID-19 and cancer patients. American Society of Clinical Oncology (ASCO) Mitigating the Spread of COVID-19 and Its Impact on Cancer COVID-19 Patient Care Information. Cancer.net. Coronavirus 2019: What People with Cancer Need to Know. CovidCancerCare.com
Currently, 4 COVID-19 vaccines are authorized for use in Canada: The Pfizer-BioNTech (Comirnaty) vaccine is approved for people 5 years of age and older. The Moderna (Spikevax) vaccine is approved for people 12 years of age and older. The AstraZeneca (Vaxzevria) vaccine is approved for people 18 years of age and older.
